가톨릭대학교 THE CATHOLIC UNIVERSITY OF KOREA가톨릭대학교 THE CATHOLIC UNIVERSITY OF KOREA의과대학

가톨릭대학교 THE CATHOLIC UNIVERSITY OF KOREA가톨릭대학교 THE CATHOLIC UNIVERSITY OF KOREA의과대학

모바일메뉴 모바일메뉴 닫기

전체메뉴보기

전체메뉴 닫기

기초의학교실


프로필 이미지

한성필 조교수

Sungpil Han

연구실적

  • 2025.06 | 교신저자 | JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 제52권 1호 , pp.34-34
    Leveraging large language models in pharmacometrics: evaluation of NONMEM output interpretation and simulation capabilities
  • 2025.04 | 공동저자 | JMIR MHEALTH AND UHEALTH, 제13권 1호 , pp.65668-65668
    Participant Adherence in Repeated-Dose Clinical Studies Using Video-Based Observation: Retrospective Data Analysis
  • 2025.02 | 공동저자 | HUMAN VACCINES & IMMUNOTHERAPEUTICS, 제21권 1호 , pp.2467554-2467554
    Mathematical modelling for vaccine efficacy trials during the future epidemics of emerging respiratory infections
  • 2023.12 | 공동저자 | TRANSLATIONAL AND CLINICAL PHARMACOLOGY (舊.임상약리학회지), 제31권 4호 , pp.226-237
    Pharmacokinetic properties of a new sustained-release pregabalin tablet in subjects with reduced renal function
  • 2023.04 | 공동저자 | DRUG DESIGN DEVELOPMENT AND THERAPY, 제17권 0호 , pp.1107-1114
    Pharmacokinetic Interactions Between Bazedoxifene and Cholecalciferol: An Open-Label, Randomized, Crossover Study in Healthy Male Volunteers
  • 2023.02 | 공동저자 | INTERNATIONAL JOURNAL OF STEM CELLS, 제16권 1호 , pp.16-26
    Establishing Rationale for the Clinical Development of Cell Therapy Products: Consensus between Risk and Benefit
  • 2023.01 | 제1저자 | GUT AND LIVER, 제17권 1호 , pp.92-99
    Comparison of Pharmacodynamics between Tegoprazan and Dexlansoprazole Regarding Nocturnal Acid Breakthrough: A Randomized Crossover Study
  • 2022.04 | 제1저자 | COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 제216권 0호 , pp.106662-106662
    DallphinAtoM: Physiologically based pharmacokinetics software predicting human PK parameters based on physicochemical properties, in vitro and animal in vivo data
  • 2022.04 | 공동저자 | FRONTIERS IN PHARMACOLOGY, 제13권 0호 , pp.853971-853971
    Urinary Profile of Endogenous Gamma-Hydroxybutyric Acid and its Biomarker Metabolites in Healthy Korean Females: Determination of Age-Dependent and Intra-Individual Variability and Identification of Metabolites Correlated With Gamma-Hydroxybutyric Acid
  • 2021.11 | 공동저자 | KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 제25권 6호 , pp.545-553
    An experience on the model-based evaluation of pharmacokinetic drug-drug interaction for a long half-life drug
  • 2021.08 | 제1저자 | CLINICAL THERAPEUTICS, 제43권 8호 , pp.1371-1380
    Effect of Food on the Pharmacokinetics and Pharmacodynamics of a Single Oral Dose of Tegoprazan
  • 2021.03 | 제1저자 | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 제106권 3호 , pp.E1111-E1120
    First-in-Human, Double-Blind, Randomized Controlled Trial of an Oral Dose of GnRH Antagonist TU2670 in Healthy Women
  • 2020.08 | 제1저자 | DRUG DESIGN DEVELOPMENT AND THERAPY, 제14권 0호 , pp.3189-3199
    First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of a Neuroprotective Poly (ADP-ribose) Polymerase-1 Inhibitor, JPI-289, in Healthy Volunteers
  • 2019.11 | 제1저자 | FRONTIERS IN PHARMACOLOGY, 제10권 0호 , pp.1419-1419
    Usefulness of Bnet, a Simple Linear Metric in Discerning Torsades De Pointes Risks in 28 CiPA Drugs
  • 2019.10 | 제1저자 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 제50권 7호 , pp.751-759
    Randomised clinical trial: safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple oral doses of tegoprazan (CJ-12420), a novel potassium-competitive acid blocker, in healthy male subjects
  • 2021.09 | 공동
    신약개발을 위한 실전 약동학 I (기본원리와 자료해석)
  • 2020.07 | 공동
    계량약리학 워크샵 - 초급 과정
  • 2023.12 | The 44th Annual Scientific Meeting of the Japanese Society of Pharmacology and Therapeutics | 국제학술대회(구연)
    Characterizing Exposure-Response Relationship for Various Therapeutics using PK-PD Modeling and Simulation
  • 2023.11 | 2023년 대한임상약리학회 추계학술대회 | 국내학술대회(포스터)
    Human Pharmacotranscriptomics Reveals Gene Expression and Immune Response Pathways Underlying Pruritus as an Adverse Reaction to Nuclear Receptor Agonist
  • 2023.11 | 2023년 대한임상약리학회 추계학술대회 | 국내학술대회(포스터)
    Zolpidemsim: A Web-Application for Simulating Plasma Zolpidem Concentration
  • 2023.11 | The Fourteenth American Conference on Pharmacometrics (ACoP14) | 국제학술대회(포스터)
    PIPETapps: a Compilation of R Shiny Apps for Clinical Pharmacology and Pharmacometrics using Cloud Computing Tools
  • 2023.11 | acop 1 | 국제학술대회(포스터)
    tu2670
  • 2023.11 | ACOP | 국제학술대회(포스터)
    PIPETAPP
  • 2023.11 | The Fourteenth American Conference on Pharmacometrics (ACoP14) | 국제학술대회(포스터)
    Pharmacokinetics and Pharmacodynamics of TU2670 (nonpeptide GnRH antagonist) in healthy female subjects
  • 2023.11 | Principles and Applications of Clinical Pharmacology and Pharmacometrics in the Drug Development | 국내학술대회(구연)
    Principles and Applications of Clinical Pharmacology and Pharmacometrics in the Drug Development
  • 2023.10 | 2023년 대한약물역학위해관리학회 추계학술대회 | 국내학술대회(구연)
    분산형 임상시험의 개념과 국내 활용가능 기술
  • 2023.08 | International Council for Industrial and Applied Mathematics 2023 | 국제학술대회(구연)
    Principles and applications of clinical pharmacology and pharmacometrics in the drug development
  • 2022.12 | 2023 대한임상약리학회 추계학술대회 | 국내학술대회(포스터)
    Pharmacokinetics and Pharmacodynamics of TU2670 (nonpeptide GnRH antagonist) in healthy female subjects
  • 2022.12 | 2022 대한임상약리학회 추계학술대회 | 국내학술대회(구연)
    RNA sequencing for pharmacotranscriptomics and its application to Clinical Pharmacology
  • 2021.11 | PAGK 2021 Annual Meeting | 국내학술대회(구연)
    Quantitative estimations of first-in-human doses of FXR agonist for the treatment of NASH
  • 2021.05 | 한국비임상시험연구회 제39차 워크샵 | 국내학술대회(구연)
    New Approaches for an Integrated Nonclinical-Clinical QT/Proarrhythmic Risk Assessment
  • 2019.11 | 2019 대한임상약리학회 추계학술대회 | 국내학술대회(구연)
    Pharmacokinetic-pharmacodynamic analysis to evaluate the effect of moxifloxacin and verapamil on electrocardiographic safety markers, J-Tpeak, Tpeak-Tend and QTc interval in healthy male subjects
  • 2019.11 | 2019 대한임상약리학회 추계학술대회 | 국내학술대회(포스터)
    Usefulness of Bnet, a simple linear metric in discerning Torsade de Pointes risks in 28 CiPA drugs
  • 2019.09 | 2019 safety pharmacology society annuual meeting | 국제학술대회(포스터)
    Evaluation of Torsade de Pointes Risks in 28 CiPA Drugs by a Simple Linear Metric, Bnet
  • 2019.05 | DDI 2019 – 10th International Workshop on Regulatory Requirements and Current Scientific Aspects on the Preclinical and Clinical Investigation of Drug-Drug Interactions | 국제학술대회(포스터)
    Dallphin-AtoM - Human pharmacokinetic parameter prediction tool using allometry and physiologically based pharmacokinetic approach
QUICK
MENU
맨위로가기